We are live on ! Find out more
SA

Sovran Advisors Portfolio holdings

AUM $1.34B
1-Year Est. Return 21.63%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+21.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.13B
AUM Growth
+$177M
Cap. Flow
+$99.2M
Cap. Flow %
8.76%
Top 10 Hldgs %
19.04%
Holding
555
New
69
Increased
253
Reduced
186
Closed
36

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.99%
2 Technology 10.61%
3 Healthcare 3.62%
4 Financials 3.32%
5 Consumer Discretionary 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTEB icon
476
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.6B
$233K 0.02%
+4,612
New +$227K
IDHQ icon
477
Invesco S&P International Developed Quality ETF
IDHQ
$1.03B
$233K 0.02%
6,735
-496
-7% -$16.3K
SLYG icon
478
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.02B
$233K 0.02%
2,504
-195
-7% -$17.9K
ENB icon
479
Enbridge
ENB
$110B
$232K 0.02%
+4,947
New +$233K
GD icon
480
General Dynamics
GD
$103B
$230K 0.02%
+668
New +$211K
FHLC icon
481
Fidelity MSCI Health Care Index ETF
FHLC
$3.47B
$230K 0.02%
3,310
-532
-14% -$34.4K
HSBC icon
482
HSBC
HSBC
$355B
$229K 0.02%
+3,248
New +$211K
UL icon
483
Unilever
UL
$140B
$227K 0.02%
3,317
+121
+4% +$8.35K
IEI icon
484
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$225K 0.02%
1,882
-99
-5% -$11.8K
FDN icon
485
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.43B
$225K 0.02%
806
-45
-5% -$12.3K
SPDW icon
486
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42B
$224K 0.02%
5,144
-1,464
-22% -$60.7K
TMO icon
487
Thermo Fisher Scientific
TMO
$230B
$222K 0.02%
+400
New +$186K
IWO icon
488
iShares Russell 2000 Growth ETF
IWO
$14.8B
$221K 0.02%
+674
New +$203K
JQUA icon
489
JPMorgan US Quality Factor ETF
JQUA
$8.7B
$217K 0.02%
3,468
-193
-5% -$11.8K
ATO icon
490
Atmos Energy
ATO
$28.2B
$217K 0.02%
+1,253
New +$202K
PH icon
491
Parker-Hannifin
PH
$125B
$217K 0.02%
+280
New +$207K
CRTC icon
492
Xtrackers US National Critical Technologies ETF
CRTC
$144M
$217K 0.02%
5,854
-1,887
-24% -$66.3K
IBN icon
493
ICICI Bank
IBN
$107B
$216K 0.02%
+7,043
New +$230K
JNK icon
494
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.67B
$216K 0.02%
2,222
+4
+0.2% +$389
FXL icon
495
First Trust Technology AlphaDEX Fund
FXL
$2.76B
$216K 0.02%
1,249
-129
-9% -$20.8K
PEG icon
496
Public Service Enterprise Group
PEG
$36.5B
$216K 0.02%
+2,674
New +$224K
IYT icon
497
iShares US Transportation ETF
IYT
$2.26B
$215K 0.02%
3,006
TT icon
498
Trane Technologies
TT
$98.8B
$214K 0.02%
480
-38
-7% -$16.2K
BCI icon
499
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.3B
$214K 0.02%
+9,723
New +$204K
MDGL icon
500
Madrigal Pharmaceuticals
MDGL
$12.3B
$214K 0.02%
+500
New +$187K

Similar funds

Sovran Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Sovran Advisors held 555 positions worth $1.13B, up 19% from $954M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Sovran Advisors deployed $99.2M of net new capital in Q3 2025, opening 69 new positions and adding to 253 existing holdings. Its largest new stake was BitMine Immersion Technologies: 160,057 shares worth $7.13M.

By sector, the portfolio is most concentrated in Miscellaneous at 72% of assets, down from 73% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $8.35M trimmed.

  • Sovran Advisors's largest Q3 2025 buy was BitMine Immersion Technologies: 160,057 shares worth $7.13M.
  • Sovran Advisors added most to BlackRock US Equity Factor Rotation ETF in Q3 2025, an estimated $4.63M increase.
  • Sovran Advisors's biggest Q3 2025 reduction was Ionis Pharmaceuticals, cutting an estimated $8.35M.
  • Sovran Advisors fully exited Summit Therapeutics in Q3 2025, selling an estimated $3.45M.
  • Sovran Advisors's ten largest holdings make up 19% of its $1.13B portfolio in Q3 2025.
  • Sovran Advisors opened 69 new positions and closed 36 in Q3 2025.
  • Sovran Advisors's portfolio value rose 19% quarter-over-quarter to $1.13B.

Based on Sovran Advisors's 13F filing for Q3 2025, filed 31 Oct 2025.